Oral and parenteral clindamycin, as well as most other antibiotics, have been associated with severe pseudomembranous colitis. The physician should be alerted to the development of antibiotic-associated diarrhoea or colitis. If diarrhoea occurs, the product should be discontinued immediately. Patients with a history of the Crohn's disease and ulcerative colitis should be observed with caution. Prescribe with caution in atopic individuals. Prolonged use of this product for several months must be under the control of a physician.
Avoid contact with eyes.
Use in Pregnancy and Lactation: Safe use of topical clindamycin in pregnancy has not been established. Caution should be exercised when clindamycin is given during breast feeding.